Skip to main content
. 2019 Jun 7;5(5):372–377. doi: 10.1016/j.ijwd.2019.05.008

Table 5.

Frequency of positive and negative anti-Dsg1/3 Ab in patients with pemphigus vulgaris who achieved CR, PR, and NR after rituximab

Anti-Dsg1
Anti-Dsg3
p-value
Negative Positive Negative Positive
CR (%) 35 (94.6) 2 (5.4) 17 (45.9) 20 (54.1) < .001
PR (%) 26 (86.7) 4 (13.3) 14 (46.7) 16 (53.3) .002
NR (%) 4 (50.0) 4 (50.0) 1 (12.5) 7 (87.5) .282

Ab, antibody; CR, complete remission; Dsg, desmoglein; PR, partial remission; NR, nonresponding